tiprankstipranks
Trending News
More News >
bioMerieux (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Financial Statements

Compare
11 Followers

bioMerieux Financial Overview

bioMerieux's market cap is currently €11.92B. The company's EPS TTM is €2; its P/E ratio is 29.67; and it has a dividend yield of 0.82%. bioMerieux is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 4.07B€ 3.98B€ 3.67B€ 3.59B€ 3.38B
Gross Profit€ 2.14B€ 2.22B€ 2.06B€ 1.96B€ 1.97B
Operating Income€ 561.20M€ 588.80M€ 439.10M€ 559.80M€ 768.00M
EBITDA€ 999.60M€ 897.50M€ 701.30M€ 811.90M€ 977.80M
Net Income€ 397.50M€ 432.20M€ 357.60M€ 452.40M€ 601.10M
Balance Sheet
Cash & Short-Term Investments€ 569.80M€ 449.80M€ 352.40M€ 552.60M€ 803.50M
Total Assets€ 5.57B€ 5.77B€ 5.26B€ 5.19B€ 4.61B
Total Debt€ 461.40M€ 490.70M€ 518.80M€ 505.40M€ 462.50M
Net Debt€ -108.40M€ 40.90M€ 166.40M€ -47.20M€ -341.00M
Total Liabilities€ 1.47B€ 1.56B€ 1.51B€ 1.54B€ 1.44B
Stockholders' Equity€ 4.10B€ 4.20B€ 3.75B€ 3.60B€ 3.11B
Cash Flow
Free Cash Flow€ 453.00M€ 321.50M€ 107.10M€ 188.40M€ 534.60M
Operating Cash Flow€ 788.30M€ 667.30M€ 445.40M€ 475.10M€ 824.70M
Investing Cash Flow€ -461.70M€ -359.80M€ -488.80M€ -528.10M€ -307.30M
Financing Cash Flow€ -155.40M€ -212.60M€ -122.30M€ -244.20M€ -140.60M
Currency in EUR

bioMerieux Earnings and Revenue History

bioMerieux Debt to Assets

bioMerieux Cash Flow

bioMerieux Forecast EPS vs Actual EPS